Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites

Biochemical Journal

Volumn 401, Issue 1, 2007, Pages 155-166

  Joshi, B ^a,b   Rastogi, S ^a   Morris, M ^a   Carastro, L M ^a,c   DeCook, C ^a   Seto, E ^a   Chellappan, S P ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF TAMPA   (United States)

Author keywords

E2F1; p53; Prohibitin; Retinoblastoma (Rb); Transcription; Yin and Yang 1 (YY1)

Indexed keywords

BINDING ENERGY; CELL CULTURE; GENES; GROWTH KINETICS;

PROHIBITIN; RETINOBLASTOMA (RB); TRANSCRIPTION;

ENZYMES;

CASPASE 7; PROTEIN P53; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR YY1;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE ACTIVATION; GENE ACTIVITY; GENE MUTATION; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROHIBITIN GENE; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN INDUCTION; TUMOR SUPPRESSOR GENE;

CASPASE 7; CELL LINE, TUMOR; DNA PRIMERS; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MUTAGENESIS; PLASMIDS; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; RNA, NEOPLASM; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; YY1 TRANSCRIPTION FACTOR;

EID: 33846286148     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20060364     Document Type: Article

References (51)

1. Sherr, C. J. (1996) Cancer cell cycles. Science 274, 1672-1677
2. Blagosklonny, M. V. (2003) Cell immortality and hallmarks of cancer. Cell Cycle 2, 296-299
3. Harbour, J. W. and Dean, D. C. (2000) The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14, 2393-2409
4. Sherr, C. J. and McCormick, F. (2002) The RB and p53 pathways in cancer. Cancer Cell 2, 103-112
5. Nevins, J. R., Leone, G., DeGregori, J. and Jakoi, L. (1997) Role of the Rb/E2F pathway in cell growth control. J. Cell Physiol. 173, 233-236
6. La Thangue, N. B. (1996) E2F and the molecular mechanisms of early cell-cycle control. Biochem. Soc. Trans. 24, 54-59
7. Korenjak, M. and Brehm, A. (2005) E2F-Rb complexes regulating transcription of genes important for differentiation and development. Curr. Opin. Genet. Dev. 15, 520-527
8. Kel, A. E., Kel-Margoulis, O. V., Farnham, P. J., Bartley, S. M., Wingender, E. and Zhang, M. Q. (2001) Computer-assisted identification of cell cycle-related genes: new targets for E2F transcription factors. J. Mol. Biol. 309, 99-120
9. Nevins, J. R. (2001) The Rb/E2F pathway and cancer. Hum. Mol. Genet. 10, 699-703
10. Chellappan, S. P., Hiebert, S., Mudryj, M., Horowitz, J. M. and Nevins, J. R. (1991) The E2F transcription factor is a cellular target for the RB protein. Cell 65, 1053-1061
11. Cobrinik, D. (2005) Pocket proteins and cell cycle control. Oncogene 24, 2796-2809
12. Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J. and Kouzarides, T. (1998) Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597-601
13. Luo, R. X., Postigo, A. A. and Dean, D. C. (1998) Rb interacts with histone deacetylase to repress transcription. Cell 92, 463-473
14. Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L. and Wolffe, A. P. (2000) DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet. 25, 338-342
15. Knudsen, E. S. and Wang, J. Y. (1996) Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J. Biol. Chem. 271, 8313-8320
16. Brown, V. D., Phillips, R. A. and Gallie, B. L. (1999) Cumulative effect of phosphorylation of pRB on regulation of E2F activity. Mol. Cell. Biol. 19, 3246-3256
17. Wang, S., Nath, N., Adlam, M. and Chellappan, S. (1999) Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene 18, 3501-3510
18. Roskams, A. J., Friedman, V., Wood, C. M., Walker, L., Owens, G. A., Stewart, D. A., Altus, M. S., Danner, D. B., Liu, X. T. and McClung, J. K. (1993) Cell cycle activity and expression of prohibitin mRNA. J. Cell. Physiol. 157, 289-295
19. Nuell, M. J., Stewart, D. A., Walker, L., Friedman, V., Wood, C. M., Owens, G. A., Smith, J. R., Schneider, E. L., Dell'Orco, R., Lumpkin, C. K. et al. (1991) Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol. Cell. Biol. 11, 1372-1381
20. Wang, S., Nath, N., Fusaro, G. and Chellappan, S. (1999) Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol. Cell. Biol. 19, 7447-7460
21. Wang, S., Fusaro, G., Padmanabhan, J. and Chellappan, S. P. (2002) Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene 21, 8388-8396
22. Wang, S., Zhang, B. and Faller, D. V. (2004) BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonists. EMBO J. 23, 2293-2303
23. Joshi, B., Ko, D., Ordonez-Ercan, D. and Chellappan, S. P. (2003) A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis. Biochem. Biophys. Res. Commun. 312, 459-466
24. Rastogi, S., Joshi, B., Dasgupta, P., Morris, M., Wright, K. and Chellappan, S. (2006) Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes. Mol. Cell. Biol. 26, 4161-4171
25. Fusaro, G., Wang, S. and Chellappan, S. (2002) Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosis. Oncogene 21, 4539-4548
26. Fusaro, G., Dasgupta, P., Rastogi, S., Joshi, B. and Chellappan, S. (2003) Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J. Biol. Chem. 278, 47853-47861
27. Rastogi, S., Joshi, B., Fusaro, G. and Chellappan, S. (2006) Camptothecin induces nuclear export of prohibitin preferentially in transformed cells through a CRM-1 dependent mechanism. J. Biol. Chem. 281, 2951-2959
28. Yao, Y. L., Dupont, B. R., Ghosh, S., Fang, Y., Leach, R. J. and Seto, E. (1998) Cloning, chromosomal localization and promoter analysis of the human transcription factor YY1. Nucleic Acids Res. 26, 3776-3783
29. Weinmann, A. S., Bartley, S. M., Zhang, T., Zhang, M. Q. and Farnham, P. J. (2001) Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol. Cell. Biol. 21, 6820-6832
30. Reference deleted
31. Sun, L., Liu, L., Yang, X. J. and Wu, Z. (2004) Akt birds prohibitin 2 and relieves its repression of MyoD and muscle differentiation, J. Cell Sci. 117, 3021-3029
32. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331
33. 32a Tang, M. K., Wang, C. M., Shan, S. W., Chui, Y. L., Ching, A. K., Chow, P. H., Grotewold, L., Chan, J. Y. and Lee, K. K. (2006) Comparative proteomic analysis reveals a function of the novel death receptor-associated protein BRE in the regulation of prohibitin and p53 expression and proliferation. Proteomics 6, 2376-2385
34. Seto, E., Shi, Y. and Shenk, T. (1991) YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro. Nature 354, 241-245
35. Shi, Y., Seto, E., Chang, L. S. and Shenk, T. (1991) Transcriptional repression by YY1, a human GLI-Kruppekelated protein, and relief of repression by adenovirus E1A protein. Cell 67, 377-388
36. Galvin, K. M. and Shi, Y. (1997) Multiple mechanisms of transcriptional repression by YY1. Mol. Cell. Biol. 17, 3723-3732
37. Gordon, S., Akopyan, G., Garban, H. and Bonavida, B. (2006) Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25, 1125-1142
38. Shi, Y., Lee, J. S. and Galvin, K. M. (1997) Everything you have ever wanted to know about Yin Yang 1. Biochim. Biophys. Acta 1332, F49-F66
39. Thomas, M. J. and Seto, E. (1999) Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 236, 197-208
40. Yeh, T. S., Lin, Y. M., Hsieh, R. H. and Tseng, M. J. (2003) Association of transcription factor YY1 with the high molecular weight Notch complex suppresses the transactivation activity of Notch. J. Biol. Chem. 278, 41963-41969
41. Nayak, B. K. and Das, G. M. (2002) Stabilization of p53 and transactivation of its target genes in response to replication blockade. Oncogene 21, 7226-7229
42. Schlisio, S., Halperin, T., Vidal, M. and Nevins, J. R. (2002) Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function. EMBO J. 21, 5775-5786
43. Cohen, G. M. (1997) Caspases: the executioners of apoptosis. Biochem. J. 326, 1-16
44. Liedtke, C., Groger, N., Manns, M. P. and Trautwein, C. (2003) The human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism. J. Biol. Chem. 278, 27593-27604
45. Gamble, S. C., Odontiadis, M., Waxman, J., Westbrook, J. A., Dunn, M. J., Wait, R., Lam, E. W. and Bevan, C. L. (2004) Androgens target prohibitin to regulate proliferation of prostate cancer cells. Oncogene 23, 2996-3004
46. Duan, H., Orth, K., Chinnaiyan, A. M., Poirier, G. G., Froelich, C. J., He, W. W. and Dixit, V. M. (1996) ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J. Biol. Chem. 271, 16720-16724
47. Fernandes-Alnemri, T., Takahashi, A., Armstrong, R., Krebs, J., Fritz, L., Tomaselli, K. J., Wang, L., Yu, Z., Croce, C. M., Salveson, G. et al. (1995) Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res. 55, 6045-6052
48. Lippke, J. A., Gu, Y., Sarnecki, C., Caron, P. R. and Su, M. S. (1996) Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32. J. Biol. Chem. 271, 1825-1828
49. Boatright, K. M. and Salvesen, G. S. (2003) Mechanisms of caspase activation. Curr. Opin. Cell Biol. 15, 725-731
50. Peterson-Roth, E., Reynolds, M., Quievryn, G. and Zhitkovicn, A. (2005) Mismatch repair proteins are activators of toxic responses to chromium-DNA damage. Mol. Cell. Biol. 25, 3596-3607
51. Pediconi, N., Ianari, A., Costanzo, A., Belloni, L., Gallo, R., Cimino, L., Porcellini, A., Screpanti, I., Balsano, C., Alesse, E. et al. (2003) Differential regulation of E2F1 apoptotic target genes in response to DNA damage. Nat. Cell Biol. 5, 552-558